ArticleFrontiers in oncology2024

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series.

Reshma Mahtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.